Anti-colorectal cancer immunity : control ‘the force’!

Leiden Repository

Anti-colorectal cancer immunity : control ‘the force’!

Title: Anti-colorectal cancer immunity : control ‘the force’!
Author: Speetjens, Franciscus Maria
Publisher: Department of Surgery, Faculty of Medicine / Leiden University Medical Center (LUMC), Leiden University
Issue Date: 2013-01-10
Keywords: Colorectal cancer
Frameshift-mutated peptide
Immunotherapy
Long peptides
P53 vaccine
Vaccination
Abstract: This dissertation reports on the relation between the immune system, colorectal cancer and immunotherapy. In the first part, expression of HLA class I and expression of CXCL5 in colocectal cancer was studied. Low expression of HLA class I in rectal tumors was associated with poor survival of rectal cancer patients. Low expression of CXCL5 in cancer cells was significantly associated with poor prognosis in a population of colorectal cancer patients and correlated with presence of intra-tumoral CD8+ T-cell infiltration. In the second part of this thesis we focused on induction of tumor specific T-cells. For immunotherapeutic purposes distinction should be made between microsatellite instable (MSI-H) and microsatellite stable (MSS) colorectal tumors, as MSI-H tumors express neo-antigens “foreign” to the immune system while immunotherapy against MSS tumors depends on tumor associated “self”-antigens. We developed a methodology predicting immunogenic behavior of frameshift-mutated antigens present in MSI-H tumors that was based on accumulation and MHC class I presentation. This method can be used to develop cancer immunotherapy of patients at risk for MSI-H tumors. In the last two chapters we described safety and immunogenicity of a p53 synthetic long peptides vaccine combined with and without Interferon-alpha. Addition of IFN-α to the p53-SLP® vaccine significantly improved p53-specific after vaccination. Altogether this dissertation reports on the relation between the immune system, colorectal cancer and immunotherapy. This knowledge can be used to further optimize immunotherapeutic strategies to treat cancer patients.
Description: Promotores: S.H. van der Burg, C.J.H. van de Velde, Co-promotor: P.J.K. Kuppen
With summary in Dutch
Faculty: LUMC
Citation: Speetjens, F.M., 2013, Doctoral thesis, Leiden University
ISBN: 9789461693372
Handle: http://hdl.handle.net/1887/20399
 

Files in this item

Description Size View
application/pdf Full text 2.719Mb View/Open
application/pdf Cover 514.4Kb View/Open
application/pdf Title page_Contents 469.3Kb View/Open
application/pdf Chapter 1 General introduction 598.5Kb View/Open
application/pdf Chapter 2 681.9Kb View/Open Full text at publisher site
application/pdf Chapter 3 556.0Kb View/Open Full text at publisher site
application/pdf Chapter 4 797.3Kb View/Open Full text at publisher site
application/pdf Chapter 5 920.7Kb View/Open Full text at publisher site
application/pdf Chapter 6 734.3Kb View/Open Full text at publisher site
application/pdf Chapter 7 1.259Mb View/Open
application/pdf Chapter 8 Summary and future perspectives 522.4Kb View/Open
application/pdf Chapter 9 Summa ... lum Vitae_Acknowledgements 502.1Kb View/Open
application/pdf Propositions 500.0Kb View/Open

This item appears in the following Collection(s)